Acceptability of Multiparticulate Dosing Using Sympfiny^® Delivery System with Children (Age 1–12)

This study investigated multiparticulate formulation administered over a two-week period of time via the Sympfiny^® system with children of ages 1–12 years. The study was conducted with parent–child pairs (N = 120 total participants) following a specific dose strategy to mimic PURIXAN’s do...

Полное описание

Библиографические подробности

Главные авторы:	Kate Abeln, Kate Cox, Laura Haggerty, Mary Beth Privitera
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2022-11-01
Серии:	Pharmaceutics
Предметы:	multiparticulate acceptability pediatric formulation palatability oral syringe administration device
Online-ссылка:	https://www.mdpi.com/1999-4923/14/11/2524
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!